AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 6996113 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferrous sulphate (60 mg elemental iron) with riboflavin (6mg)
Number of subjects: 101
Study 6996113 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 101
Study 31125164 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing gum (long-term group, 19 days)
Number of subjects: 100
Study 31125164 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing gum (short-term group, 7 days)
Number of subjects: 100
Study 29358012 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-daily eliglustat dosing
Number of subjects: 170
Study 29358012 — intervention group
Group type: COMPARATOR
Intervention: Twice-daily eliglustat dosing
Number of subjects: 170
Study 29358012 — intervention group
Group type: EXPERIMENTAL
Intervention: Both dosing regimens
Number of subjects: 170
Study 29358012 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-daily and twice-daily dosing
Number of subjects: 170
Study 27488042 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular powder (RP)
Number of subjects: 12
Study 27488042 — intervention group
Group type: EXPERIMENTAL
Intervention: Dust-free bleaching powder (DFP)
Number of subjects: 12
Study 24673517 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipswich Touch Test
Number of subjects: 331
Study 24673517 — intervention group
Group type: COMPARATOR
Intervention: 10-g monofilament testing
Number of subjects: 331
Study 21841525 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep brain stimulation of periaqueductal grey
Number of subjects: 37
Study 21841525 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep brain stimulation of subthalamic nucleus
Number of subjects: 37
Study 21841525 — intervention group
Group type: COMPARATOR
Intervention: Control nuclei stimulation (sensory thalamus and globus pallidus interna)
Number of subjects: 37
Study 21841525 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep brain stimulation overall
Number of subjects: 37
Study 21841525 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in thoracic diameter
Number of subjects: 37
Study 21841525 — intervention group
Group type: EXPERIMENTAL
Intervention: Forced expiratory volume in 1 second
Number of subjects: 37
Study 20381162 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright white light
Number of subjects: 73
Study 20381162 — intervention group
Group type: EXPERIMENTAL
Intervention: High-density negative ions
Number of subjects: 73
Study 20381162 — intervention group
Group type: COMPARATOR
Intervention: Dim red light
Number of subjects: 73
Study 20381162 — intervention group
Group type: COMPARATOR
Intervention: Low-density negative ions
Number of subjects: 73
Study 18445980 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy plus alpha-tocopherol supplementation (400 IU/day)
Number of subjects: 0
Study 18445980 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy alone (6000 cGy in five fractions per week for 6 weeks)
Number of subjects: 0
Study 15897788 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxazosin 4 mg/d
Number of subjects: 96
Study 15897788 — intervention group
Group type: COMPARATOR
Intervention: Irbesartan 300 mg/d
Number of subjects: 96
Study 12370460 — intervention group
Group type: EXPERIMENTAL
Intervention: IV glucose infusion
Number of subjects: 5
Study 12370460 — intervention group
Group type: COMPARATOR
Intervention: Oral glucose
Number of subjects: 5
Study 12370460 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study 12370460 — intervention group
Group type: COMPARATOR
Intervention: IV glucose in healthy subjects
Number of subjects: 5
Study 9843903 — intervention group
Group type: EXPERIMENTAL
Intervention: L-NAME 1 microg. kg‐1. min‐1 for 30 min
Number of subjects: 12
Study 9843903 — intervention group
Group type: EXPERIMENTAL
Intervention: L-NAME 5 microg. kg‐1. min‐1 for 30 min
Number of subjects: 12
Study 9843903 — intervention group
Group type: EXPERIMENTAL
Intervention: L-NAME 25 microg. kg‐1. min‐1 for 30 min
Number of subjects: 12
Study 9843903 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 7598322 — intervention group
Group type: EXPERIMENTAL
Intervention: Self palpation and mammography
Number of subjects: 0
Study 7598322 — intervention group
Group type: EXPERIMENTAL
Intervention: Preservative therapy (QUART)
Number of subjects: 0
Study 2606014 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole (Flagyl)
Number of subjects: 0
Study 2606014 — intervention group
Group type: EXPERIMENTAL
Intervention: Tinidazole (Fasigyn)
Number of subjects: 0
Study 2606014 — intervention group
Group type: COMPARATOR
Intervention: Generic Metronidazole (Metrozol)
Number of subjects: 0
Study 2606014 — intervention group
Group type: COMPARATOR
Intervention: Generic Tinidazole (Tynazole)
Number of subjects: 0
Study 1122668 — intervention group
Group type: EXPERIMENTAL
Intervention: Deltoid muscle blood flow (MBF)
Number of subjects: 20
Study 1122668 — intervention group
Group type: COMPARATOR
Intervention: Gluteus muscle blood flow (MBF)
Number of subjects: 20
Study 29310548 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy focusing on interpersonal mechanisms of change
Number of subjects: 0
Study 29310548 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 28383947 — intervention group
Group type: EXPERIMENTAL
Intervention: TBI factsheet
Number of subjects: 164
Study 28383947 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal stories of people with TBI
Number of subjects: 164
Study 28383947 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 164
Study 26109111 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent audit and feedback intervention delivered by telephone and email, consisting of 2-4 canteen menu audits over 12 months.
Number of subjects: 72
Study 26109111 — intervention group
Group type: COMPARATOR
Intervention: Usual support (control group).
Number of subjects: 72
Study 23829646 — intervention group
Group type: EXPERIMENTAL
Intervention: Football training 2x1 h · week(‐1) for 16 weeks
Number of subjects: 27
Study 23829646 — intervention group
Group type: COMPARATOR
Intervention: Elite trained (ET)
Number of subjects: 27
Study 22364067 — intervention group
Group type: EXPERIMENTAL
Intervention: Cultural competency training and race-stratified performance reports
Number of subjects: 17
Study 19857446 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower dose (LD) of vaccine
Number of subjects: 40
Study 19857446 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher dose (HD) of vaccine
Number of subjects: 40
Study 19857446 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 16918564 — intervention group
Group type: EXPERIMENTAL
Intervention: Bleomycin tattoo
Number of subjects: 45
Study 16918564 — intervention group
Group type: COMPARATOR
Intervention: Cryotherapy combined with intralesional triamcinolon injection
Number of subjects: 45
Study 15579914 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen 40 mg/d
Number of subjects: 0
Study 15579914 — intervention group
Group type: EXPERIMENTAL
Intervention: Megestrol acetate 160 mg/d
Number of subjects: 0
Study 11360530 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture at Yin Meridians
Number of subjects: 45
Study 11360530 — intervention group
Group type: COMPARATOR
Intervention: Control group treated at Yang Meridians
Number of subjects: 45
Study 9564292 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraperitoneal polyglactin mesh
Number of subjects: 288
Study 9564292 — intervention group
Group type: COMPARATOR
Intervention: No intraperitoneal polyglactin mesh (control group)
Number of subjects: 288
Study 9564292 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 288
Study 8062504 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-hydroxybutyrate infusion
Number of subjects: 10
Study 8062504 — intervention group
Group type: COMPARATOR
Intervention: saline infusion (control)
Number of subjects: 10
Study 2663407 — intervention group
Group type: EXPERIMENTAL
Intervention: Aceclofenac 100 mg
Number of subjects: 60
Study 2663407 — intervention group
Group type: COMPARATOR
Intervention: Paracetamol 650 mg
Number of subjects: 60
Study 31067329 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 540
Study 31067329 — intervention group
Group type: EXPERIMENTAL
Intervention: ASP1707 3 mg
Number of subjects: 540
Study 31067329 — intervention group
Group type: EXPERIMENTAL
Intervention: ASP1707 5 mg
Number of subjects: 540
Study 31067329 — intervention group
Group type: EXPERIMENTAL
Intervention: ASP1707 10 mg
Number of subjects: 540
Study 31067329 — intervention group
Group type: EXPERIMENTAL
Intervention: ASP1707 15 mg
Number of subjects: 540
Study 31067329 — intervention group
Group type: EXPERIMENTAL
Intervention: Leuprorelin
Number of subjects: 540
Study 29231604 — intervention group
Group type: EXPERIMENTAL
Intervention: Fire acupuncture with centro-square needles (FACSN)
Number of subjects: 72
Study 29231604 — intervention group
Group type: COMPARATOR
Intervention: Filiform needling (FN)
Number of subjects: 72
Study 26383549 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive bias modification via the Approach Avoidance Task (implicit training to avoid gaming cues)
Number of subjects: 38
Study 26383549 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive bias modification via the Approach Avoidance Task (implicit training to approach gaming cues)
Number of subjects: 38
Study 23199566 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive remediation targeting basic cognitive processes (RECOS)
Number of subjects: 63
Study 23199566 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive remediation targeting autobiographical memory (REMAu)
Number of subjects: 63
Study 23199566 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive remediation targeting metacognitive deficits (MBCT)
Number of subjects: 63
Study 21946824 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 40
Study 21946824 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 40
Study 18424971 — intervention group
Group type: EXPERIMENTAL
Intervention: Coregistered ultrasound
Number of subjects: 35
Study 18424971 — intervention group
Group type: COMPARATOR
Intervention: Preoperative MRI scans
Number of subjects: 35
Study 16434517 — intervention group
Group type: EXPERIMENTAL
Intervention: CT-based navigation
Number of subjects: 90
Study 16434517 — intervention group
Group type: EXPERIMENTAL
Intervention: Imageless navigation
Number of subjects: 90
Study 16434517 — intervention group
Group type: COMPARATOR
Intervention: Freehand placement
Number of subjects: 90
Study 12032174 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary long-chain n-3 PUFA (fish oil) for 6 weeks
Number of subjects: 51
Study 10090350 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 10
Study 10090350 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 7594098 — intervention group
Group type: EXPERIMENTAL
Intervention: tissue-type plasminogen activator (t-PA)
Number of subjects: 1473
Study 7594098 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 1473
Study 7594098 — intervention group
Group type: EXPERIMENTAL
Intervention: early invasive management strategy
Number of subjects: 1473
Study 7594098 — intervention group
Group type: COMPARATOR
Intervention: early conservative strategy
Number of subjects: 1473
Study 2246790 — intervention group
Group type: EXPERIMENTAL
Intervention: Sex and aging workshop
Number of subjects: 20
Study 2246790 — intervention group
Group type: COMPARATOR
Intervention: Control group (no workshop)
Number of subjects: 20
Study 7001687 — intervention group
Group type: EXPERIMENTAL
Intervention: Levamisole hydrochloride (100 mg initially followed by 100 mg twice daily for 10 days)
Number of subjects: 78
Study 7001687 — intervention group
Group type: COMPARATOR
Intervention: Diethylcarbamazine citrate (DEC) at 126 mg per kg body-weight
Number of subjects: 78
Study 6341623 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative disinfection with chlorhexidine
Number of subjects: 65
Study 6341623 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular cephradine followed by oral nitrofurantoin
Number of subjects: 65
Study 6341623 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine disinfection followed by oral nitrofurantoin
Number of subjects: 65
Study 6341623 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 65
Study 31892215 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA alone
Number of subjects: 0
Study 31892215 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA with oat beta-glucan
Number of subjects: 0
Study 31892215 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA with anthocyanins
Number of subjects: 0
Study 31892215 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 29546292 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (1-g capsules containing ≥840 mg n-3 PUFAs as ethyl esters) with preoperative loading of 8-10 g over 2-5 days followed by 2 g/day until hospital discharge or postoperative day 10.
Number of subjects: 320
Study 29546292 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 320
Study 26673130 — intervention group
Group type: EXPERIMENTAL
Intervention: Heated water-based exercise (HEx)
Number of subjects: 18
Study 26673130 — intervention group
Group type: EXPERIMENTAL
Intervention: Land-based exercise (LEx)
Number of subjects: 18
Study 26673130 — intervention group
Group type: COMPARATOR
Intervention: Nonexercise control (CON)
Number of subjects: 18
Study 24952862 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 15488
Study 23019945 — intervention group
Group type: EXPERIMENTAL
Intervention: Jiangtang Xiaozhi Capsule (JTXZC)
Number of subjects: 73
Study 23019945 — intervention group
Group type: COMPARATOR
Intervention: Pioglitazone tablet
Number of subjects: 73
Study 19696752 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-year group intervention designed to promote autonomous self-regulation of body weight
Number of subjects: 225
Study 19696752 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 225
Study 19696752 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-year group intervention
Number of subjects: 225
Study 17304654 — intervention group
Group type: EXPERIMENTAL
Intervention: Abatacept
Number of subjects: 1043
Study 17304654 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1043
Study 15914135 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifepristone 200 mg orally and Misoprostol 800 mcg vaginally
Number of subjects: 80
Study 12074256 — intervention group
Group type: EXPERIMENTAL
Intervention: Almonds supplement (76 kJ daily) for six months
Number of subjects: 81
Study 12074256 — intervention group
Group type: COMPARATOR
Intervention: Control (no almonds) during the first six months
Number of subjects: 81
Study 10335000 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment (inhaled budesonide 200‐400 microg twice daily + terbutaline 500‐1000 microg four times daily)
Number of subjects: 61
Study 10335000 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide (200‐400 microg twice daily)
Number of subjects: 61
Study 10335000 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline (500‐1000 microg four times daily)
Number of subjects: 61
Study 10335000 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 10335000 — intervention group
Group type: COMPARATOR
Intervention: Terbutaline
Number of subjects: 61
Study 10335000 — intervention group
Group type: COMPARATOR
Intervention: Budesonide
Number of subjects: 61
Study 10335000 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment
Number of subjects: 61
Study 7769306 — intervention group
Group type: EXPERIMENTAL
Intervention: 480 mg TMP-SMZ once a day
Number of subjects: 260
Study 7769306 — intervention group
Group type: EXPERIMENTAL
Intervention: 960 mg TMP-SMZ once a day
Number of subjects: 260
Study 2284577 — intervention group
Group type: EXPERIMENTAL
Intervention: Amikacin plus piperacillin
Number of subjects: 69
Study 2284577 — intervention group
Group type: COMPARATOR
Intervention: Ceftazidime
Number of subjects: 69
Study 373645 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Number of subjects: 2
Study 373645 — intervention group
Group type: EXPERIMENTAL
Intervention: Azathioprine
Number of subjects: 2
Study 373645 — intervention group
Group type: COMPARATOR
Intervention: Symptomatic treatment alone
Number of subjects: 2
Study 31110097 — intervention group
Group type: EXPERIMENTAL
Intervention: STOP trained staff
Number of subjects: 30
Study 31110097 — intervention group
Group type: COMPARATOR
Intervention: Untrained staff
Number of subjects: 30
Study 31110097 — intervention group
Group type: EXPERIMENTAL
Intervention: NHS SSS leaflets
Number of subjects: 30
Study 31110097 — intervention group
Group type: EXPERIMENTAL
Intervention: Trained counter staff
Number of subjects: 30
Study 31110097 — intervention group
Group type: EXPERIMENTAL
Intervention: Body language use
Number of subjects: 30
Study 31110097 — intervention group
Group type: EXPERIMENTAL
Intervention: Key phrases from STOP training
Number of subjects: 30
Study 31110097 — intervention group
Group type: EXPERIMENTAL
Intervention: STOP promotional badges
Number of subjects: 30
Study 28522317 — intervention group
Group type: EXPERIMENTAL
Intervention: 17-alpha hydroxyprogesterone caproate
Number of subjects: 268
Study 28522317 — intervention group
Group type: COMPARATOR
Intervention: CYP single nucleotide polymorphisms *22, *1G, *1B, and *3
Number of subjects: 268
Study 28522317 — intervention group
Group type: COMPARATOR
Intervention: Progesterone receptor single nucleotide polymorphisms rs578029, rs471767, rs666553, rs503362, and rs500760
Number of subjects: 268
Study 23601741 — intervention group
Group type: EXPERIMENTAL
Intervention: High monounsaturated fat hypocaloric diet (Diet M)
Number of subjects: 261
Study 23601741 — intervention group
Group type: COMPARATOR
Intervention: High polyunsaturated fat hypocaloric diet (Diet P)
Number of subjects: 261
Study 22108479 — intervention group
Group type: EXPERIMENTAL
Intervention: Pycnogenol® (100 mg daily for 8 weeks)
Number of subjects: 38
Study 22108479 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 38
Study 22108479 — intervention group
Group type: EXPERIMENTAL
Intervention: Pycnogenol®
Number of subjects: 38
Study 22108479 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 38
Study 19705494 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular diclofenac (75 mg loading dose) and isotonic saline infusion (5-10 mL/kg per hour over 4 hours)
Number of subjects: 80
Study 19705494 — intervention group
Group type: COMPARATOR
Intervention: Placebo (500 mL isotonic saline infusion)
Number of subjects: 80
Study 17307303 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette Dependence Scale (CDS)
Number of subjects: 700
Study 17307303 — intervention group
Group type: EXPERIMENTAL
Intervention: Fagerstrom Test for Nicotine Dependence Scale (FTND)
Number of subjects: 700
Study 17307303 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine Dependence Syndrome Scale (NDSS)
Number of subjects: 700
Study 15070908 — intervention group
Group type: EXPERIMENTAL
Intervention: Levothyroxine (L-T4) supplementation for 7 months in cohort 1 and 11 months in cohort 2.
Number of subjects: 24
Study 15070908 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 7 months in cohort 1 and 11 months in cohort 2.
Number of subjects: 24
Study 15070908 — intervention group
Group type: COMPARATOR
Intervention: Placebo group measurements of TSH and Tg during AR.
Number of subjects: 24
Study 12426264 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency treatment for obstructive pulmonary disease
Number of subjects: 43
Study 10442911 — intervention group
Group type: EXPERIMENTAL
Intervention: Cataract surgery
Number of subjects: 763
Study 10442911 — intervention group
Group type: COMPARATOR
Intervention: Unoperated persons with normal vision
Number of subjects: 763
Study 10442911 — intervention group
Group type: COMPARATOR
Intervention: Unoperated persons with visual acuity less than 0.05 in both eyes
Number of subjects: 763
Study 10442911 — intervention group
Group type: COMPARATOR
Intervention: Unoperated population
Number of subjects: 763
Study 7491853 — intervention group
Group type: EXPERIMENTAL
Intervention: Cu-Safe 300 IUD
Number of subjects: 600
Study 7491853 — intervention group
Group type: COMPARATOR
Intervention: TCu380A IUD
Number of subjects: 600
Study 2178599 — intervention group
Group type: EXPERIMENTAL
Intervention: IM ephedrine 25 mg
Number of subjects: 0
Study 2178599 — intervention group
Group type: EXPERIMENTAL
Intervention: IM scopolamine 0.1 mg
Number of subjects: 0
Study 2178599 — intervention group
Group type: EXPERIMENTAL
Intervention: IM dimenhydrinate
Number of subjects: 0
Study 2178599 — intervention group
Group type: EXPERIMENTAL
Intervention: IM metoclopramide
Number of subjects: 0
Study 2178599 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 2178599 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 mg scopolamine
Number of subjects: 0
Study 7424843 — intervention group
Group type: EXPERIMENTAL
Intervention: Microtraining
Number of subjects: 25
Study 7424843 — intervention group
Group type: EXPERIMENTAL
Intervention: Programmed learning
Number of subjects: 25
Study 7424843 — intervention group
Group type: COMPARATOR
Intervention: No-training control
Number of subjects: 25
Study 30595567 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan 25 mg daily
Number of subjects: 54
Study 30595567 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 54
Study 26178634 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetyl glucosamine (100 mg) and chondroitin sulfate (180 mg) daily for 24 weeks
Number of subjects: 50
Study 26178634 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 50
Study 26178634 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetyl glucosamine and chondroitin sulfate
Number of subjects: 50
Study 24559909 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse facilitated, cognitive behavioural self-management programme
Number of subjects: 0
Study 24559909 — intervention group
Group type: COMPARATOR
Intervention: Usual care including un-facilitated access to the same manual
Number of subjects: 0
Study 22281781 — intervention group
Group type: EXPERIMENTAL
Intervention: Local microwave diathermy
Number of subjects: 92